Vestcor Inc Incyte Corp Transaction History

Vestcor Inc

$3.35 Billion
Q3 2025

A detailed history of Vestcor Inc transactions in Incyte Corp stock. As of the latest transaction made, Vestcor Inc holds 116,846 shares of INCY stock, worth $12.2 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

116,846

Previous 7,591 1439.27%

Holding current value

$12.2 Million

Previous $517,000 1816.83%

% of portfolio

0.3%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$67.27 - $86.96 $7.35 Million - $9.5 Million	109,255 Added 1439.27%	116,846 $9.91 Million
Q2 2025 Aug 08, 2025	BUY	$55.17 - $71.22 $273,422 - $352,966	4,956 Added 188.08%	7,591 $517,000
Q1 2025 May 08, 2025	BUY	$60.0 - $75.26 $1,080 - $1,354	18 Added 0.69%	2,635 $160,000
Q4 2024 Feb 10, 2025	SELL	$65.08 - $83.38 $520 - $667	-8 Reduced 0.3%	2,617 $181,000
Q3 2024 Nov 15, 2024	SELL	$57.33 - $68.61 $984,184 - $1.18 Million	-17,167 Reduced 86.74%	2,625 $174,000

Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $2.98 Million - $3.71 Million	-58,228 Reduced 74.63%	19,792 $1.2 Million
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $446,688 - $525,994	-7,899 Reduced 9.19%	78,020 $4.45 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $2,190 - $2,695	-42 Reduced 0.05%	85,919 $5.4 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $147,140 - $167,923	2,547 Added 3.05%	85,961 $4.97 Million
Q2 2023 Aug 15, 2023	SELL	$60.95 - $75.51 $172,671 - $213,919	-2,833 Reduced 3.28%	83,414 $5.19 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $284,150 - $347,996	4,046 Added 4.92%	86,247 $6.23 Million
Q4 2022 Feb 15, 2023	BUY	$67.18 - $84.11 $1.7 Million - $2.13 Million	25,363 Added 44.62%	82,201 $6.6 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $96,291 - $120,561	1,455 Added 2.63%	56,838 $3.79 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $1.54 Million - $1.94 Million	23,337 Added 72.82%	55,383 $4.21 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $1.88 Million - $2.27 Million	28,517 Added 808.08%	32,046 $2.55 Million
Q4 2021 Feb 15, 2022	SELL	$63.34 - $74.11 $36,990 - $43,280	-584 Reduced 14.2%	3,529 $259,000
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $25,476 - $31,171	-371 Reduced 8.27%	4,113 $283,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $26,516 - $29,059	-332 Reduced 6.89%	4,484 $377,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $6,005 - $7,939	-79 Reduced 1.61%	4,816 $391,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $16,551 - $20,028	-205 Reduced 4.02%	4,895 $426,000
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $4,848 - $6,252	-57 Reduced 1.11%	5,100 $458,000
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $98,585 - $144,767	1,329 Added 34.72%	5,157 $536,000
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $45,995 - $62,586	728 Added 23.48%	3,828 $280,000
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $226,424 - $296,732	3,100 New	3,100 $271,000

Others Institutions Holding INCY

# of Institutions

795

Shares Held

205M

Call Options Held

638K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account